Skip to content

Clareon CNW0T6 (UDI 00380652411196)Recalls & reported problems

Alcon Laboratories, Inc. · CLAREON BLF TORIC · Class 3 · Implant

All models of Clareon (1142)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00380652411196), received between Apr 25, 2024 and Jul 11, 2025 — classified as 3 malfunctions.

The most frequently reported specific device problem is “Material Split, Cut or Torn” (3 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 1 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 2 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Material Split, Cut or Torn3
  • Crack1

Patient problems

  • No Clinical Signs, Symptoms or Conditions2
  • Insufficient Information1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJul 11, 2025Material Split, Cut or Torn; Material Split, Cut or Torn

    A FACILITY REPRESENTATIVE REPORTED THAT DURING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, LENS WAS LOADING USING COMPANY CARTRIDGE AND VISCOELASTIC. WHEN THE SURGEON WAS INJECTING THE LENS INTO THE EYE, HE FELT SOME RESISTANCE. ONCE THE IOL WAS IN THE PATIENT'S EYE, SURGEON NOTED THAT THE LENS HAD A CRACK. SURGEON REMOVED THE LENS AND REPLACED WITH ANOTHER LENS. IT WAS STATED THAT THE REASON FOR USING THE COMPANY CARTRIDGE WAS AS IT WAS NOTED ON THE PACKAGING AS THE CARTRIDGE TO USE. PROCEDURE COMPLETED ON THE SAME DAY. THIS REPORT IS ASSOCIATED WITH MULTIPLE COMPLAINTS. THIS FILE IS 1 OF 2. ADDITIONAL INFORMATION HAS BEEN REQUESTED AND RECEIVED STATING THAT THERE WAS NO PATIENT HARM.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 22480850 ↗
  • MalfunctionJul 11, 2025Material Split, Cut or Torn; Material Split, Cut or Torn

    A FACILITY REPRESENTATIVE REPORTED THAT DURING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, LENS WAS LOADING USING COMPANY CARTRIDGE AND VISCOELASTIC. WHEN THE SURGEON WAS INJECTING THE LENS INTO THE EYE, HE FELT SOME RESISTANCE. ONCE THE IOL WAS IN THE PATIENT'S EYE, SURGEON NOTED THAT THE LENS HAD A CRACK. SURGEON REMOVED THE LENS AND REPLACED WITH ANOTHER LENS. AGAIN RESISTANCE WAS FELT AND NOTED THAT THE LENS HAD A CRACK. REMOVED THIS LENS AND REPLACED WITH ANOTHER LENS IT WAS STATED THAT THE REASON FOR USING THE COMPANY CARTRIDGE WAS AS IT WAS NOTED ON THE PACKAGING AS THE CARTRIDGE TO USE. PROCEDURE WAS COMPLETED ON THE SAME DAY. THIS REPORT IS ASSOCIATED WITH MULTIPLE COMPLAINTS. THIS FILE IS 2 OF 2. ADDITIONAL INFORMATION HAS BEEN REQUESTED AND RECEIVED STATING THAT THERE WAS NO PATIENT HARM.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 22480841 ↗
  • MalfunctionApr 25, 2024Crack; Material Split, Cut or Torn; Crack; Material Split, Cut or Torn

    A SURGEON REPORTED WITH A DESCRIPTION OF DURING INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE HAPTIC WAS TORN WHEN THE LENS WAS IMPLANTED, CAUSING A CRACK IN THE OPTICAL PART. IT HAS BEEN CONFIRMED THAT THE INJECTOR, CARTRIDGE, AND OVD WERE USED PROPERLY. THE SURGERY HAS NOW BEEN COMPLETED AND THE TORN LENS HAS BEEN IMPLANTED AS IT WAS. THE SURGEON PLANS TO CONSIDER WHETHER TO REPLACE THE PATIENT BASED ON THE POSTOPERATIVE COURSE. THE TORN HAPTIC AND CARTRIDGE WERE RETURNED. ADDITIONAL INFORMATION HAS BEEN RECEIVED STATING THE SURGEON CONSIDERS THAT IT WAS UNLIKELY THAT THE CARTRIDGE WAS A FACTOR.

    Patient problems: Insufficient Information

    MAUDE report 19181150 ↗

Other intraocular lens devices

All intraocular lens devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page